Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use.
Kidney transplantation from deceased donors classified as increased risk for viral infection by the Centers for Disease Control (CDC) is controversial. Analyses of Organ Procurement and Transplantation Network (OPTN) data from 7/1/2004 to 7/1/2006 were performed. The primary cohort included 48 054 adults added to the kidney transplant wait list. Compared to receiving a standard criteria donor (SCD) kidney or remaining wait-listed, CDC recipients (HR 0.80, p = 0.18) had no significant difference in mortality. In a secondary cohort of 19 872 kidney recipients at 180 centers, SCD (reference) and CDC (HR 0.91, p = 0.16) recipients had no difference in the combined endpoint of allograft failure or death. Among centers performing >10 kidney transplants during the study period, the median proportion of CDC transplants/total transplants was 7.2% (range 1.1-35.6%). Higher volume transplant centers were more likely to use CDC kidneys compared to low and intermediate volume centers (p < 0.01). An analysis of procured kidneys revealed that 6.8% of SCD versus 7.8% of CDC (p = 0.13) kidneys were discarded. In summary, center use of CDC kidneys varied widely, and recipients had good short-term outcomes. OPTN should collect detailed data about long-term outcomes and recipient viral testing so the potential risks of CDC kidneys can be fully evaluated.
Reese
P P
PP
Department of Medicine, Renal Division, Center for Clniical Epidemiology and Biostatistics and Leonard Davis Institute of Health Economics, University of Pennsylvania, Pennsylvania, PA, USA. peter.reese@uphs.upenn.edu
Feldman
H I
HI
Asch
D A
DA
Halpern
S D
SD
Blumberg
E A
EA
Thomasson
A
A
Shults
J
J
Bloom
R D
RD
D017848:Blood-Borne Pathogens; D002487:Centers for Disease Control and Prevention, U.S.; D015331:Cohort Studies; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D014019:Tissue Donors; D016896:Treatment Outcome; D014481:United States; D014777:Virus Diseases / Q000635:transmission*
J Am Soc Nephrol. 2001 Mar;12(3):589-597
11181808
Am J Transplant. 2007 Jun;7(6):1515-25
17511680
Am J Transplant. 2007 Jul;7(7):1797-807
17524076
Ann Intern Med. 1998 May 15;128(10):817-26
9599193
Clin J Am Soc Nephrol. 2006 May;1(3):532-8
17699256
MMWR Recomm Rep. 1994 May 20;43(RR-8):1-17
8183226
JAMA. 2005 Dec 7;294(21):2726-33
16333008
N Engl J Med. 2008 Sep 11;359(11):1182; author reply 1182-3
18784113
Transplantation. 2008 Jun 15;85(11):1588-94
18551064
Ann Epidemiol. 2000 Feb;10(2):74-80
10691060
J Community Health. 1999 Aug;24(4):285-303
10463472
Can J Public Health. 2005 Mar-Apr;96(2):97-101
15850026
Am J Transplant. 2005 Jan;5(1):139-44
15636622
N Engl J Med. 2008 Jun 26;358(26):2832-7
18579820
N Engl J Med. 1999 Dec 2;341(23):1725-30
10580071
Am J Transplant. 2009 Mar;9(3):620-8
19191766
Am J Transplant. 2007 Dec;7(12):2769-74
17927805
Am J Kidney Dis. 2008 Sep;52(3):553-86
18725015
N Engl J Med. 2004 Aug 19;351(8):751-9
15317888
Am J Transplant. 2007 Dec;7(12):2652-4
17983389